Loading...

Novo Nordisk gears up for explosive growth in weight-loss and diabetes treatments

Published
11 Feb 25
Updated
08 Mar 25
n/a
n/a
Unike's Fair Value
n/a
Loading
1Y
-58.4%
7D
-1.0%

Author's Valuation

DKK 1.04k70.0% undervalued intrinsic discount

Unike's Fair Value